Latest AI and machine learning research in nephrology for healthcare professionals.
Optimizing meropenem dosing in critically ill patients undergoing continuous renal replacement thera...
Percutaneous nephrostomy is widely used in kidney access surgeries. Despite its prevalence in urolog...
BACKGROUND: Vancomycin-resistant Enterococcus (VRE) infection is a life-threatening complication aft...
BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a severe disease with limited effectiv...
Patients with advanced lung adenocarcinoma have a range of treatment options, including targeted the...
Long-term effectiveness of digital health interventions for hypertension remains unclear, particular...
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide despite major advances...
BACKGROUND: Primary glomerulonephritis (GN) is a heterogeneous group of kidney disorders where under...
Electrolyte design plays an important role in the development of lithium-ion batteries and sodium-io...
BACKGROUND AND PURPOSE: The telomerase reverse transcriptase (TERT) gene promoter mutation is a cruc...
The relationship between abdominal body composition and chronic kidney disease (CKD) is well-documen...
The ability to predict the three-dimensional structure of a protein from its amino acid sequence has...
Fundus parameters can be used to quantify masculinity or femininity as a fundus sex index (FSI) rang...
Renal disease represents a significant public health concern, with renal microvascular lesions playi...
Neoadjuvant systemic therapy has emerged as a strategy to improve outcomes in high-risk localized ge...
Colchicine, a well-known microtubule assembly inhibitor that binds to β-tubulin, has limited clinica...
The validation of promising clinical biomarkers, molecular mechanisms, and novel drug targets in car...
Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder with high mortality, necessita...
UNLABELLED: : Background and Hypothesis: Monoallelic pathogenic variants in GANAB cause autosomal do...
BACKGROUND: Immune checkpoint inhibitor therapy (ICI) with nivolumab+ipilimumab is a first-line (1L)...